Interleukin-1 Inhibition and Fatigue in Primary Sjögren's Syndrome – A Double Blind, Randomised Clinical Trial

Open Access

Peer-reviewed

Research Article

Katrine Brække Norheim ,

* E-mail: nokb@sus.no

Affiliation Clinical Immunology Unit, Department of Internal Medicine, Stavanger University Hospital, Stavanger, Norway
⨯
Erna Harboe,

Affiliation Clinical Immunology Unit, Department of Internal Medicine, Stavanger University Hospital, Stavanger, Norway
⨯
Lasse G. Gøransson,

Affiliations Clinical Immunology Unit, Department of Internal Medicine, Stavanger University Hospital, Stavanger, Norway, Institute of Internal Medicine, University of Bergen, Bergen, Norway
⨯
Roald Omdal

Affiliations Clinical Immunology Unit, Department of Internal Medicine, Stavanger University Hospital, Stavanger, Norway, Institute of Internal Medicine, University of Bergen, Bergen, Norway
⨯

Reader Comments (0)

Fatigue
Is the Subject Area "Fatigue" applicable to this article?

Thanks for your feedback.
Drug therapy
Is the Subject Area "Drug therapy" applicable to this article?

Thanks for your feedback.
Animal behavior
Is the Subject Area "Animal behavior" applicable to this article?

Thanks for your feedback.
Cerebrospinal fluid
Is the Subject Area "Cerebrospinal fluid" applicable to this article?

Thanks for your feedback.
Sjogren syndrome
Is the Subject Area "Sjogren syndrome" applicable to this article?

Thanks for your feedback.
Drug administration
Is the Subject Area "Drug administration" applicable to this article?

Thanks for your feedback.
Nurses
Is the Subject Area "Nurses" applicable to this article?

Thanks for your feedback.
Receptor antagonist therapy
Is the Subject Area "Receptor antagonist therapy" applicable to this article?

Thanks for your feedback.